Advanced Search
Contact | Corporate | Help

A Study of rhuMAb IFNalpha in Adults With Systemic Lupus Erythematosus

Sponsors:
  • Genentech
Phases:
  • Phase I
IndicationsAcronym:
  • Systemic Lupus Erythematosus
Age Groups:
  • Adult
Gender:
Both
Names:
  • Drug: rhuMAb IFNalpha
Enrollment:
60

Additional information about NCT00541749.


SourceSolution © 2008-2012